DK1962869T3 - Behandling af luftvejssygdomme - Google Patents

Behandling af luftvejssygdomme

Info

Publication number
DK1962869T3
DK1962869T3 DK06840529.9T DK06840529T DK1962869T3 DK 1962869 T3 DK1962869 T3 DK 1962869T3 DK 06840529 T DK06840529 T DK 06840529T DK 1962869 T3 DK1962869 T3 DK 1962869T3
Authority
DK
Denmark
Prior art keywords
treatment
respiratory diseases
respiratory
diseases
Prior art date
Application number
DK06840529.9T
Other languages
English (en)
Inventor
Mays Tamer Y El
Francis H Y Green
Samuel Schurch
Original Assignee
Solaeromed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solaeromed Inc filed Critical Solaeromed Inc
Application granted granted Critical
Publication of DK1962869T3 publication Critical patent/DK1962869T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/131—Amines acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK06840529.9T 2005-12-21 2006-12-21 Behandling af luftvejssygdomme DK1962869T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59784105P 2005-12-21 2005-12-21
PCT/CA2006/002102 WO2007071052A1 (en) 2005-12-21 2006-12-21 Treatment of respiratory diseases

Publications (1)

Publication Number Publication Date
DK1962869T3 true DK1962869T3 (da) 2013-06-24

Family

ID=38188230

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06840529.9T DK1962869T3 (da) 2005-12-21 2006-12-21 Behandling af luftvejssygdomme

Country Status (7)

Country Link
US (2) US8454938B2 (da)
EP (1) EP1962869B1 (da)
AU (1) AU2006329199B8 (da)
CA (1) CA2633099C (da)
DK (1) DK1962869T3 (da)
ES (1) ES2414957T3 (da)
WO (1) WO2007071052A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007071052A1 (en) * 2005-12-21 2007-06-28 Uti Limited Partnership Treatment of respiratory diseases
WO2009052631A1 (en) * 2007-10-26 2009-04-30 Uti Limited Partnership Ventilation stabilization system
EP2587917A4 (en) * 2010-07-01 2015-05-06 Mtm Res Llc THERAPIES USING ANTIFIBROBLASTIC FLUOROCHEMICAL EMULSIONS
CA2928759A1 (en) * 2013-11-04 2015-05-07 Board Of Regents, The University Of Texas System Compositions and methods for administration of an enzyme to a subject's airway
AU2015213681B2 (en) 2014-02-10 2020-03-12 Respivant Sciences Gmbh Mast cell stabilizers for lung disease treatment
US9962363B2 (en) 2014-02-10 2018-05-08 Patara Pharma, LLC Mast cell stabilizers treatment for systemic disorders
US20160101246A1 (en) * 2014-10-10 2016-04-14 Solaeromed Inc. Apparatus and methods for producing and delivering a vapour medicament
EP4186548A1 (en) 2015-04-02 2023-05-31 Hill-Rom Services PTE. LTD. Mask leakage detection for a respiratory device
US10238625B2 (en) 2015-08-07 2019-03-26 Respivant Sciences Gmbh Methods for the treatment of mast cell related disorders with mast cell stabilizers
WO2017027402A1 (en) 2015-08-07 2017-02-16 Patara Pharma, LLC Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
JP2019528320A (ja) 2016-08-31 2019-10-10 レシュピファント サイエンシス ゲゼルシャフト ミット ベシュレンクター ハフトゥングＲｅｓｐｉｖａｎｔ Ｓｃｉｅｎｃｅｓ Ｇｍｂｈ 特発性肺線維症による慢性咳の治療のためのクロモリン組成物
WO2018067341A1 (en) 2016-10-07 2018-04-12 Patara Pharma, LLC Cromolyn compositions for treatment of pulmonary fibrosis
WO2021207051A1 (en) * 2020-04-06 2021-10-14 Bristol-Myers Squibb Company Methods of treating acute respiratory disorders
WO2023039605A1 (en) * 2021-09-13 2023-03-16 The Board Of Regents Of The University Of Texas System Systemic injection of superheated perfluorocarbon emulsion to improve ventilation and reduce ventilator-induced lung injury

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5562608A (en) * 1989-08-28 1996-10-08 Biopulmonics, Inc. Apparatus for pulmonary delivery of drugs with simultaneous liquid lavage and ventilation
US5773024A (en) * 1989-12-22 1998-06-30 Imarx Pharmaceutical Corp. Container with multi-phase composition for use in diagnostic and therapeutic applications
DE122008000012I2 (de) * 1990-12-05 2012-04-12 Gen Hospital Corp Vorrichtung zum Behandeln einen Lungengefassverengung und von Asthma.
CA2102321C (en) * 1991-05-03 1999-11-09 Simon Nicholas Faithfull Partial liquid breathing of fluorocarbons
US5470885A (en) * 1993-09-29 1995-11-28 The Research Foundation Of The State University Of New York Fluorocarbons as anti-inflammatory agents
US5837699A (en) * 1994-01-27 1998-11-17 Schering Corporation Use of mometasone furoate for treating upper airway passage diseases
US5531219A (en) * 1994-11-04 1996-07-02 Alliance Pharmaceutical Corp. Use of liquid fluorocarbons to facilitate pulmonary drug delivery
US6001332A (en) * 1995-02-16 1999-12-14 The Boc Group Plc Medical gas mixture
GB9502987D0 (en) 1995-02-16 1995-04-05 Boc Group Plc Medical gas mixture
US5770585A (en) * 1995-05-08 1998-06-23 Kaufman; Robert J. Homogeneous water-in-perfluorochemical stable liquid dispersion for administration of a drug to the lung of an animal
US6411852B1 (en) * 1997-04-07 2002-06-25 Broncus Technologies, Inc. Modification of airways by application of energy
US6679859B1 (en) * 1997-10-24 2004-01-20 Alliance Pharmaceutical Corp. Amelioration of ischemic damage using synthetic oxygen carriers
DE19823606C2 (de) * 1998-05-27 2002-02-28 Draeger Medical Ag Verwendung von Perfluorcarbone in einem Atemgasgemisch sowie die Vorrichtung
CA2396165C (en) * 2000-01-14 2011-01-04 John F. Hunt Airway alkalinization as therapy for airway diseases
FR2812197B1 (fr) * 2000-07-27 2003-01-03 Air Liquide Sante Int Utilisation de co dans le traitement de l'inflammation des voies aeriennes superieures ou des bronches
US6878751B1 (en) * 2000-10-19 2005-04-12 Imperial College Of Science Technology And Medicine Administration of resveratrol to treat inflammatory respiratory disorders
US6455028B1 (en) * 2001-04-23 2002-09-24 Pharmascience Ipratropium formulation for pulmonary inhalation
WO2003047603A2 (en) 2001-12-04 2003-06-12 Minnesota High-Tech Resources, Llc Breathable gas mixtures to change body temperature
US7767232B2 (en) * 2002-09-19 2010-08-03 New York University Control of nitric oxide bioactivity by perfluorocarbons
WO2007071052A1 (en) * 2005-12-21 2007-06-28 Uti Limited Partnership Treatment of respiratory diseases

Also Published As

Publication number Publication date
US8454938B2 (en) 2013-06-04
AU2006329199B8 (en) 2014-01-09
AU2006329199A1 (en) 2007-06-28
EP1962869A4 (en) 2011-01-12
EP1962869B1 (en) 2013-03-20
AU2006329199B2 (en) 2013-12-12
US20070190183A1 (en) 2007-08-16
US20130316021A1 (en) 2013-11-28
CA2633099C (en) 2015-04-21
EP1962869A1 (en) 2008-09-03
CA2633099A1 (en) 2007-06-28
AU2006329199A8 (en) 2014-01-09
WO2007071052A1 (en) 2007-06-28
ES2414957T3 (es) 2013-07-23

Similar Documents

Publication Publication Date Title
DK1962869T3 (da) Behandling af luftvejssygdomme
DK1937633T3 (da) Biphenyloxyeddikesyrederivater til behandling af respiratoriske sygdomme
DK1817282T3 (da) Til behandling af respiratoriske sygdomme egnede phenoxy derivater
DK2222272T3 (da) Behandling af luftvejssygdom
DK2056807T3 (da) Behandling af inflammatoriske sygdomme
DK1890684T3 (da) Behandling af søvn/vågenhedsforstyrrelser
DK1708992T3 (da) Sulfonamidderivater til behandling af sygdomme
DK1856975T3 (da) Behandling af havebrugsafgrøder
DK1874781T3 (da) Dihydrothienopyrimidiner til behandling af inflammatoriske sygdomme
DK1945277T3 (da) Opretholdelse af desinfektion af medicinsk udstyr
DE602006016150D1 (de) Vorbeugung von krankheiten bei kaiserschnitt-babies
DK2422786T3 (da) Nye lægemiddelkombinationer til behandling af luftvejssygdomme
DK3456707T3 (da) 4-(p-quinonyl)-2-hydroxybutanamidderivater til behandling af mitokondriesygdomme
DK2056842T3 (da) Modificeret galactosylceramid til behandling af cancerøse sygdomme
DK2474321T3 (da) Sammensætninger til behandling af collagenmedierede sygdomme
DK2004204T3 (da) Behandling af neurodegenerative sygdomme med selenat
DK1940409T3 (da) Nye lægemiddelkombinationer til behandling af åndedrætssygdomme
DK1744781T3 (da) Behandling af infektionssygdomme
DK1708991T3 (da) Sulfonamid derivater til behandling af sygdomme
DK1685834T3 (da) Anvendelse af pinolensyre til behandling af obesitet
DK1863899T3 (da) Hudbehandlingspræparater
DK2236149T3 (da) Medicinsk sammensætning til behandling af respiratoriske infektions-sygdomme
BRPI0815551A2 (pt) Tratamento através de hucbc de doença beta-amiloide
NO20055643D0 (no) Preparation of lodixanol
DK2117565T3 (da) Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme